Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

AbstractAboutThe 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Pulmonary Hypertension

  Free Subscription


Articles published in J Perinatol

Retrieve available abstracts of 28 articles:
HTML format



Single Articles


    November 2025
  1. GARCIA-GOZALO M, Jain A, Weisz DE, Jasani B, et al
    Can N-terminal pro-brain natriuretic peptide accurately diagnose chronic pulmonary hypertension among extremely low gestational age neonates: A Retrospective Cohort Study.
    J Perinatol. 2025 Nov 13. doi: 10.1038/s41372-025-02462.
    PubMed     Abstract available


    April 2025
  2. MULLALY R, Smith A, Murphy C, Armstrong S, et al
    Characteristics and outcomes of preterm infants with early pulmonary hypertension.
    J Perinatol. 2025 Apr 11. doi: 10.1038/s41372-025-02295.
    PubMed     Abstract available


    March 2025
  3. WREN JT JR, Patel N, Harting MT, McNamara PJ, et al
    Hemodynamic precision to guide surgical timing for neonates with congenital diaphragmatic hernia: a narrative review.
    J Perinatol. 2025 Mar 19. doi: 10.1038/s41372-025-02265.
    PubMed     Abstract available


    July 2024
  4. BHATT DR, Braun D, Dizon RA, Shi JM, et al
    Retrospective study of preterm infants exposed to inhaled nitric oxide in Kaiser Permanente Southern California: morbidity, mortality and follow-up.
    J Perinatol. 2024 Jul 18. doi: 10.1038/s41372-024-02051.
    PubMed     Abstract available


  5. SANTELICES F, Masoli D, Kattan J, Toso A, et al
    Vasopressin as adjunctive therapy in pulmonary hypertension associated with refractory systemic hypotension in term newborns.
    J Perinatol. 2024 Jul 4. doi: 10.1038/s41372-024-02015.
    PubMed     Abstract available


    February 2024
  6. HICKS TD, Cameron J, Wang S, Ashrafi A, et al
    Assessing the role of tracheostomy placement in bronchopulmonary dysplasia with pulmonary hypertension.
    J Perinatol. 2024 Feb 5. doi: 10.1038/s41372-024-01881.
    PubMed     Abstract available


    January 2024
  7. MORONTA SC, Bischoff AR, Ryckman KK, Dagle JM, et al
    Clinical and echocardiography predictors of response to first-line acetaminophen treatment in preterm infants with hemodynamically significant patent ductus arteriosus.
    J Perinatol. 2024 Jan 31. doi: 10.1038/s41372-024-01883.
    PubMed     Abstract available


  8. CERVERA SB, Saeed S, Luu TM, Gorgos A, et al
    Evaluation of the association between patent ductus arteriosus approach and neurodevelopment in extremely preterm infants.
    J Perinatol. 2024 Jan 26. doi: 10.1038/s41372-024-01877.
    PubMed     Abstract available


    October 2023
  9. FIKE CD, Aschner JL, Avachat C, Birnbaum AK, et al
    Multi-dose enteral L-citrulline administration in premature infants at risk of developing pulmonary hypertension associated with bronchopulmonary dysplasia.
    J Perinatol. 2023 Oct 31. doi: 10.1038/s41372-023-01809.
    PubMed     Abstract available


  10. KILMARTIN KC, Al Balushi A, Altit G, Lapointe A, et al
    Impact of persistent pulmonary hypertension and oxygenation on brain injury in neonates with neonatal encephalopathy treated with therapeutic hypothermia.
    J Perinatol. 2023 Oct 23. doi: 10.1038/s41372-023-01805.
    PubMed     Abstract available


  11. BEER L, Rivera BK, Jama W, Slaughter JL, et al
    Association of the respiratory severity score with bronchopulmonary dysplasia-associated pulmonary hypertension in infants born extremely preterm.
    J Perinatol. 2023 Oct 18. doi: 10.1038/s41372-023-01798.
    PubMed     Abstract available


    August 2023
  12. TIMBERLINE S, Bhatt A, Sunderji S, Tancredi DJ, et al
    Novel scoring tool of hypoxemic respiratory failure and pulmonary hypertension for defining severity of persistent pulmonary hypertension of newborn.
    J Perinatol. 2023 Aug 25. doi: 10.1038/s41372-023-01762.
    PubMed     Abstract available


  13. ZHU F, Ibarra Rios D, Joye S, Baczynski M, et al
    Cardiopulmonary physiological effects of diuretic therapy in preterm infants with chronic pulmonary hypertension.
    J Perinatol. 2023 Aug 7. doi: 10.1038/s41372-023-01742.
    PubMed     Abstract available


  14. OSMAN A, Halling C, Crume M, Al Tabosh H, et al
    Meconium aspiration syndrome: a comprehensive review.
    J Perinatol. 2023 Aug 5. doi: 10.1038/s41372-023-01708.
    PubMed     Abstract available


  15. STEFLIK HJ, Wessler LA, Shugart WW, Wagner CL, et al
    Indomethacin patent ductus arteriosus prophylaxis in the modern era: renal implications.
    J Perinatol. 2023;43:1045-1046.
    PubMed    


    February 2023
  16. SHARMA P, Beam K, Levy P, Beam AL, et al
    PD(AI): the role of artificial intelligence in the management of patent ductus arteriosus.
    J Perinatol. 2023;43:257-258.
    PubMed    


    December 2022
  17. MURPHY C, Bussmann N, Staunton D, McCallion N, et al
    The effect of patent ductus arteriosus treatment with paracetamol on pulmonary vascular resistance.
    J Perinatol. 2022;42:1697-1698.
    PubMed    


    November 2022
  18. EL-KHUFFASH A, McNamara PJ, Breatnach C, Bussmann N, et al
    The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (MINT 1).
    J Perinatol. 2022 Nov 16. pii: 10.1038/s41372-022-01562.
    PubMed     Abstract available


    September 2022
  19. STEFLIK HJ, Brinton DL, Corrigan C, Wagner CL, et al
    Costs associated with acute kidney injury in critically Ill neonates with patent Ductus arteriosus: pediatric health information system (PHIS) analysis.
    J Perinatol. 2022 Sep 7. pii: 10.1038/s41372-022-01499.
    PubMed     Abstract available


    August 2022
  20. DE CARVALHO NUNES G, Wutthigate P, Simoneau J, Dancea A, et al
    The biventricular contribution to chronic pulmonary hypertension of the extremely premature infant.
    J Perinatol. 2022 Aug 25. pii: 10.1038/s41372-022-01497.
    PubMed     Abstract available


  21. PARK L, Donohue L, Lakshminrusimha S, Sankaran D, et al
    Intravitreal bevacizumab injection for retinopathy of prematurity and pulmonary hypertension.
    J Perinatol. 2022 Aug 15. pii: 10.1038/s41372-022-01489.
    PubMed    


    June 2022
  22. AVITABILE CM, Zhang X, Ampah SB, Wang Y, et al
    Factors associated with discontinuation of pulmonary vasodilator therapy in children with bronchopulmonary dysplasia-associated pulmonary hypertension.
    J Perinatol. 2022 Jun 8. pii: 10.1038/s41372-022-01421.
    PubMed     Abstract available


    May 2022
  23. MEMON N, Griffin I
    Correspondence: "Patent ductus arteriosus shunt elimination results in a reduction in adverse outcomes: a post hoc analysis of the PDA RCT cohort".
    J Perinatol. 2022;42:692.
    PubMed    


    April 2022
  24. GIEN J, Kinsella JP, Behrendt NJ, Zaretsky MV, et al
    Improved survival for infants with severe congenital diaphragmatic hernia.
    J Perinatol. 2022 Apr 23. pii: 10.1038/s41372-022-01397.
    PubMed     Abstract available


  25. CARPENTER RJ, Srdanovic N, Rychlik K, Sen SK, et al
    The association between pulmonary vascular disease and respiratory improvement in infants with type I severe bronchopulmonary dysplasia.
    J Perinatol. 2022 Apr 9. pii: 10.1038/s41372-022-01386.
    PubMed     Abstract available


  26. SALLMON H, Koestenberger M, Avian A, Reiterer F, et al
    Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension.
    J Perinatol. 2022 Apr 1. pii: 10.1038/s41372-022-01374.
    PubMed     Abstract available


    January 2022
  27. DILLARD J, Pavlek LR, Korada S, Chen B, et al
    Worsened short-term clinical outcomes in a cohort of patients with iNO-unresponsive PPHN: a case for improving iNO responsiveness.
    J Perinatol. 2022;42:37-44.
    PubMed     Abstract available


    October 2021
  28. YURTTUTAN S, Gullu UU
    Neonatal AKI in late preterm infants with patent ductus arteriosus.
    J Perinatol. 2021;41:2383-2384.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.